Avinash Teli1*, Azaz Ahmad1, Danish Azad2, Mohd Ajmal2, Shaziya Sheikh3 and Arvind Kumar3
1Department of Clinical Pharmacology, Nayati Medicity, Mathura, Uttar Pradesh,
2Department of Clinical Pharmacology, Eternal Hospital, Jaipur, Rajasthan, India
2Departement of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, India
3Outreach Department, Nayati Medicity, Mathura, Uttar Pradesh, India
3Department of Quality, Sarvodaya Hospital, Faridabad, Haryana, India
*Corresponding Author: Avinash Teli, Head of Clinical Pharmacology, Nayati Medicity, Mathura, Uttar Pradesh, India.
Received: March 23, 2020; Published: April 17, 2020
An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to β-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the natural host. These policies included large-scale quarantine, strict controls on travel and extensive monitoring of suspected cases. However, it is unknown whether these policies have had an impact on the epidemic. We sought to show how these control measures impacted the containment of the epidemic. The novel coronavirus uses the same receptor, angiotensin- converting enzyme 2 (ACE2) as that for SARS-CoV and mainly spreads through the respiratory tract. Importantly, increasingly evidence showed sustained human-to-human transmission, along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, cough, fatigue and a small population of patients appeared gastrointestinal infection symptoms
Keywords: COVID-19; nCOv-2019; Corona Virus; Respiratory Depression; Corporate Hospital; Guidelines; Hand Hygiene; Pandemic
Citation: Avinash Teli., et al. “A Complete Overview and Guidelines for nCOv-2019 (COVID-19) with Special Reference to Corporate Hospital". Acta Scientific Microbiology 3.5 (2020): 81-96.
Copyright: © 2020 Avinash Teli., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.